Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study

OBJECTIVE: To evaluate the ability of fluorescence optical imaging (FOI) Xiralite in the discrimination between rheumatoid arthritis (RA) patients with and without need of rituximab (RTX) retherapy—in comparison to clinical, laboratory and musculoskeletal ultrasound parameters. PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridha Ali, Schahrasad Lisa, Glimm, Anne-Marie, Burmester, Gerd R, Hoff, Paula, Schmittat, Gabriela, Hermann, Sandra, Backhaus, Marina, Klotsche, Jens, Ohrndorf, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336220/
https://www.ncbi.nlm.nih.gov/pubmed/34344678
http://dx.doi.org/10.1136/bmjopen-2020-047713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336220/
https://www.ncbi.nlm.nih.gov/pubmed/34344678
http://dx.doi.org/10.1136/bmjopen-2020-047713

Ejemplares similares